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Anti-Mta, which recognizes an antigen in the MNS blood group sys-
tem, was detected during prenatal testing of a para 6, gravida 1
woman with no history of transfusions.  Her husband was apparent-
ly Mt(a–).  Anti-Mta was first reported in 1962 as a naturally occurring
antibody directed against a new antigen in the MNS system.  The last
report in the literature of detection of anti-Mta was in 1972.
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Key Words: low-incidence antigen, anti-Mta
Anti-Mta,an antibody that recognized a new antigen in
the MNS blood group system, was first reported in 1962
by Swanson and Matson.1 The patient was a Caucasian
female with a diagnosis of cancer whose serum reacted
strongly at room temperature with red blood cells
(RBCs) from a blood donor (Mr. Martin). After alloanti-
bodies to common antigens were excluded using a stan-
dard reagent RBC panel, the patient’s serum was tested
against RBCs known to express low-incidence antigens.
Two additional antibodies, anti-Swa and -Tra, were weak-
ly reactive in the patient’s serum.
RBCs from the Mt(a+) donor (Martin) were tested
with anti-Mia, -Vw, -Kpa, -Wra, -Bea -Dia, -Mg, -By, -Lua, -Swa,
-Vr, -Mu, -Cx, -Wb, -Good, -Tra, -Sta, -Ria, and -Pra. No reac-
tivity was observed. The donor’s RBCs were reactive
with two sera known to contain multiple antibodies to
low-incidence antigens. It was confirmed that Martin’s
RBCs expressed a “new” antigen when sera from both
individuals were adsorbed with his RBCs and none of
the known low-incidence antigens were removed.
In 1965, Konugres et al.2 reported producing anti-Mta
in rabbits. After screening the RBCs of over 12,000 indi-
viduals, these authors found the incidence of the Mta
antigen to be 1:500. No association was seen with any
ethnic group, but Mta appeared to be inherited with
Ns.1,2
The first case of immune anti-Mta was reported by
Field et al.3 in 1972. In that case, the patient’s third child
was jaundiced at birth and required exchange transfu-
sion. The father’s RBCs, extensively tested with antibod-
ies to low-incidence antigens, reacted only with anti-Mta.
The previous two children had inherited the Mta antigen
and were the source of the patient’s sensitization.
Case Report
A blood sample from a 35-year-old group O Caucasian
female, para 6, gravida 1, was referred to us for identifi-
cation of an antibody to a low-incidence antigen. The
patient’s serum reacted with one of three reagent anti-
body screening cells by a 37°C low-ionic-strength saline-
antiglobulin test (LISS-AGT) during prenatal testing.
Material and Methods
Reagent RBC panels were obtained from Ortho-
Clinical Diagnostics (Raritan, NJ) and Immucor, Inc.
(Norcross, GA). Testing of the serum was performed
by a standard tube AGT4 using LISS, polyethylene gly-
col (PEG), and anti-IgG. LISS and PEG were obtained
from BCA Division of Biopool® International (West
Chester, PA) and anti-IgG from the American Red
Cross (Washington, DC). The patient’s serum was also
tested with cells expressing low-incidence antigens
available on reagent RBC panels or on RBCs stored in
liquid nitrogen. The patient’s serum was further test-
ed with two known Mt(a+) RBCs by saline, LISS, and
PEG-AGTs, and with the Mt(a+) RBCs pretreated with
ficin.
The serum was treated with dithiotreitol (DTT) to
determine whether the antibody was IgM.
An adsorption-elution method was used to deter-
mine the Mta phenotype of the husband’s group B
RBCs. One volume of his RBCs was incubated with
two volumes of the patient’s group O serum at 37°C
for 30 minutes. An eluate was performed using a com-
mercial kit (Elu-kit II) from Gamma Biologicals
(Houston, TX) and tested using reagent RBCs and
Mt(a+) RBCs according to manufacturer’s directions.
Results
The patient’s serum was nonreactive when tested
with reagent RBC panels and RBCs positive for Jsa,
Lua, Hil, Lsa, Wra, Crawford, Dia, Cx, Rd, Mg, Mur, He,
Ana, Dantu, Sta, Mit,Tcc, Lu:14, Swa, Kpa, Cob,V, Cw, and
Ytb.
Reactivity was observed with an Mt(a+) RBC when
tested by either LISS (3+), PEG (3+), or saline-AGT
(1+) methods. There was no reactivity at 37°C.
Testing of an additional Mt(a+) sample gave similar
reactivity and confirmed specificity. The positive
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screening cell was not tested for Mta for lack of an
anti-Mta reagent. Pretreatment of the two Mt(a+) RBCs
with ficin eliminated reactivity with the patient’s
serum.5
DTT results were inconclusive. The saline AGT con-
trol was 1+ whereas the treated serum AGT was +w.
The eluate from the husband’s cells was nonreactive
with the group O reagent screening RBCs and two
sources of Mt(a+) RBCs. Both the patient’s adsorbed and
untreated serum reacted 1+ with the Mt(a+) RBCs by a
standard saline antiglobulin tube method. Because the
eluate was nonreactive and the serum reactivity was not
decreased by adsorption with the husband’s RBCs, he
appears to be Mt(a–).
Discussion
The last report of anti-Mta in the literature was more
than 20 years ago. The first report in 1962 indicated the
patient’s antibody recognized a new antigen in the MNS
system, reacted at room temperature, and was naturally
occurring. The serum also contained two additional anti-
bodies to low-incidence antigens. The anti-Mta reported
in 1972 was immune in nature and caused hemolytic dis-
ease of the newborn. No additional antibodies to low-
incidence antigens were reported in that serum.
The anti-Mta in this current case only reacted by AGT
using anti-IgG. Because there was no confirmed history
of transfusion or pregnancy as a source of sensitization,
the anti-Mta appears to be a naturally occurring IgG 
antibody.
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